Those who could be most influential in bringing about change aren’t doing anything to achieve it.
prescription drugs
Another View: Biden’s Medicare drug price plan is good medicine for Americans
How do we know that? Big Pharma is fighting all the way, already in court to stop it.
Commentary: Health insurers can’t avoid covering weight-loss drugs forever
Evidence is mounting that drugs like Ozempic and Wegovy not only help patients lose weight but also help prevent heart attacks and strokes.
Another View: FDA has tools to stop drug shortages. It should use them.
Supplies of more than 300 medications are running dangerously low across the U.S. The government shouldn’t stand for it.
Commentary: Tornado at Pfizer plant exposes fragility of drug supply chain
The U.S. needs a strategic reserve of its most important medicines.
Commentary: Alzheimer’s drug Leqembi gets full FDA nod, but hurdles remain
The rollout is likely to take longer than patients and their families would like.
Merck sues U.S., calling Biden move to cut drug prices ‘extortion’
Merck argues the negotiation process outlined in President Biden’s Inflation Reduction Act violates the Constitution.
Mainers navigate shortage of critical ADHD medication
Widely known by its brand names, including Adderall, the drug has been a life-changer for people with attention-deficit/hyperactivity disorder.
Commentary: Insulin price cuts could lift drugmakers’ profits
New rules designed to reduce Medicaid’s costs give pharma companies incentive to be less opaque.
Biden says he’s focused ‘intensely’ on lowering drug costs
The president – gearing up for an expected reelection announcement – aims to make the effort central to his policy and political agenda.